Accordingly, the current study used the AGS, SCM-1, TMK-1 and MKN-45 gastric cancer cell lines to investigate whether RPN2 expression is a candidate target for chemotherapy in gastric cancers, one of the most frequent human cancers worldwide. Here, RPN2 is linked to gastric cancer.